AGREEMENT AND PLAN OF MERGER by and among: Genoptix, Inc., Stone MArger Sub Ltd., and ROSETTA GENOMICS LTD. Dated as of February 27, 2018Merger Agreement • March 13th, 2018 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2018 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of February 27, 2018 (the “Agreement Date”), by and among Genoptix, Inc., a Delaware corporation (“Parent”), Stone Marger Sub Ltd., a company incorporated under the Laws of the State of Israel (“Merger Sub”), and Rosetta Genomics Ltd., a company incorporated under the Laws of the State of Israel (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
AGREEMENT AND PLAN OF MERGER by and among: Genoptix, Inc., Stone Merger Sub Ltd., and ROSETTA GENOMICS LTD. Dated as of December 14, 2017Merger Agreement • December 21st, 2017 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledDecember 21st, 2017 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of December 14, 2017 (the “Agreement Date”), by and among Genoptix, Inc., a Delaware corporation (“Parent”), Parent on behalf of Stone Merger Sub Ltd. (or any other name approved by the Registrar of Companies of the State of Israel (the “Companies Registrar”)), a company in formation in accordance with the Laws of the State of Israel (“Merger Sub”), and Rosetta Genomics Ltd., a company incorporated under the Laws of the State of Israel (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.